About the project

The aim of the HMR test bed is to improve care for people who have, or may develop, certain long term health conditions. Initially it is focused on three conditions; COPD, heart failure and type 2 diabetes. These have been chosen as the areas where the test bed could make the biggest difference.

The HMR test bed combines new approaches to data analysis with the application of telehealth. There are three components to the project, which will be deployed in general practices in Heywood, Middleton and Rochdale.

  • Data management software, developed by MSD, will help GP practices to identify those patients at greatest risk of long term ill health. Additionally, Verily will seek to develop insights that the NHS can use to analyse individual health information by using advanced analytics to identify cohorts of patients for screening and interventional services. By analysing patient’s health data, the software will help practices identify potentially vulnerable patients earlier, so that they are able to intervene sooner.
  • Practice staff will be supported to make the best use of the new intelligence they gain from health data through a structured development programme called “Evidence into Practice”. The programme upskills primary health care teams to develop practice which is informed by data insights.
  • Selected patients with long term heart and lung conditions will be able to take advantage of a telehealth service, called “Closercare”, which is provided by MSD. Patients with COPD or heart failure will be provided with digital devices to monitor their own vital health signs at home, sending the readings to health professionals who will monitor them remotely for changes in their condition.

The test bed project will run until 2018. It is being evaluated independently by the University of Manchester to assess its impact and potential for wider application within the NHS.